Literature DB >> 11349478

Bipolar disorder.

P E Keck1, S L McElroy, L M Arnold.   

Abstract

Bipolar disorder (manic-depressive illness) is a common, recurrent, and severe psychiatric disorder that affects 1% to 3% of the US population. The illness is characterized by episodes of mania, depression, or mixed states (simultaneously occurring manic and depressive symptoms). Bipolar disorder frequently goes unrecognized and untreated for many years without clinical vigilance. New screening tools have been developed to assist physicians in making the diagnosis. Fortunately, several medications are now available to treat the acute mood episodes of bipolar disorder and to prevent further episodes with maintenance treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349478     DOI: 10.1016/s0025-7125(05)70334-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

Review 1.  Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.

Authors:  Toni M Dando; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Management options for bipolar disorder in children and adolescents.

Authors:  Arman Danielyan; Robert A Kowatch
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 3.  Molecular and genetic basis of depression.

Authors:  Madhumita Roy; Madhu G Tapadia; Shobhna Joshi; Biplob Koch
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

Review 4.  Pharmacological control of acute agitation: focus on intramuscular preparations.

Authors:  Dan L Zimbroff
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Shiou-Lan Chen; Yun-Hsuan Chang; Po-See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Yi-Hsin Yang; Ru-Band Lu; Cheng-Sheng Chen
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

6.  A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole.

Authors:  Salvatore Gentile
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

Review 7.  Lurasidone as a potential therapy for bipolar disorder.

Authors:  Young Sup Woo; Hee Ryung Wang; Won-Myong Bahk
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-08       Impact factor: 2.570

8.  Evaluation of the Effect of Memantine Supplementation in the Treatment of Acute Phase of Mania in Bipolar Disorder of Elderly Patients: A Double-blind Randomized Controlled Trial.

Authors:  Victoria Omranifard; Mohammad Javad Tarrahi; Shima Sharifi; Mojgan Karahmadi
Journal:  Adv Biomed Res       Date:  2018-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.